TAM
CUE icon

TFG Asset Management’s Cue Biopharma CUE Stock Holding History

TFG Asset Management’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96M Buy
+93,819
New +$2.12M 0.47% 31

Other funds holding CUE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return

TFG Asset Management's CUE Position: Q2 2026 in Review

TFG Asset Management opened a new position in Cue Biopharma (CUE) in Q2 2026: 93,819 shares worth $2.96M. The stake represents 0.47% of the portfolio and ranks #31 among its holdings.

46 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • TFG Asset Management held 93,819 shares of Cue Biopharma worth $2.96M as of Q2 2026.
  • Cue Biopharma was a new TFG Asset Management position in Q2 2026.
  • Cue Biopharma made up 0.47% of TFG Asset Management's portfolio in Q2 2026, its #31 holding.
  • 46 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on TFG Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.